Odomzo is classified as a Hedgehog pathway inhibitor and helps to block this molecular pathway which is active in basal cell (skin) cancers. By suppressing the Hedgehog pathway, Odomzo may stop or slow the growth of cancer lesions. Specifically, Odomzo binds to and inhibits Smoothened, a protein involved in this pathway.